Continuous subcutaneous glucose monitoring in type 1 diabetic patients treated by implantable insulin pump versus pancreas or islets transplantation

被引:0
|
作者
Kessler, L
Benhamou, PY
Passemard, R
Meyer, L
Oberholzer, J
Penfornis, F
Bader, L
Wolf, P
Morel, P
Pinget, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A87 / A87
页数:1
相关论文
共 50 条
  • [31] THE DAWN PHENOMENON IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS TREATED BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    CONSOLI, A
    CAPANI, F
    DELLALOGGIA, F
    MASSIBENEDETTI, M
    VITACOLONNA, E
    SENSI, S
    DIABETOLOGIA, 1983, 25 (02) : 148 - 148
  • [32] Treatment satisfaction of type 1 diabetic patients: Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injection
    Galatzer, A
    Weintrob, N
    Cohen, D
    Benzaquen, H
    Rimer, A
    Ofan, R
    Mittelman, I
    Faiman, G
    Phillip, M
    DIABETES, 2002, 51 : A619 - A619
  • [33] Insulin glargine improves glycemic control assessed by subcutaneous continuous glucose monitoring in patients with type 1 diabetes
    Delles, C
    Janisch, HD
    DIABETES, 2004, 53 : A461 - A461
  • [34] The continuous measurement of interstitial glucose: a vector of behavior change in type 1 diabetic patients under an insulin pump
    Joannidis, S.
    Crozet, C.
    DIABETES & METABOLISM, 2012, 38 : A49 - A49
  • [35] The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
    T. Battelino
    I. Conget
    B. Olsen
    I. Schütz-Fuhrmann
    E. Hommel
    R. Hoogma
    U. Schierloh
    N. Sulli
    J. Bolinder
    Diabetologia, 2012, 55 : 3155 - 3162
  • [36] The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
    Battelino, T.
    Conget, I.
    Olsen, B.
    Schuetz-Fuhrmann, I.
    Hommel, E.
    Hoogma, R.
    Schierloh, U.
    Sulli, N.
    Bolinder, J.
    DIABETOLOGIA, 2012, 55 (12) : 3155 - 3162
  • [37] Comparison of antigenicity of Hoechst 21 PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients
    Jeandidier, N
    Boullu, S
    Busch-Brafin, MS
    Chabrier, G
    Sapin, I
    Gasser, F
    Pinget, M
    DIABETES CARE, 2002, 25 (01) : 84 - 88
  • [38] Use and Discontinuation of Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring in Paediatric Patients with Type 1 Diabetes: Rates and Causes
    Shalitin, Shlomit
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 23 - 23
  • [39] Effects on glycaemic variability and glyco-metabolic control of an insulin pump integrated with continuous glucose monitoring system in type 1 diabetic patients
    Maffioli, P.
    Romano, D.
    D'Angelo, A.
    Derosa, G.
    DIABETOLOGIA, 2015, 58 : S98 - S98
  • [40] Variability in Basal Insulin Needs in Young Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring with Predictive Low Glucose Insulin Suspension
    De Tezanos-Pinto, A.
    Pichott, M.
    Barra, A.
    Avila, A.
    Cassorla, F.
    Codner, E.
    Gaete, X.
    Mericq, V
    Roman, R.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 21 - 22